Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LEPONEX 200 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LEPONEX 200 MG COMPRIMIDOS

Approved

STANDARD

LEPONEX 200 MG COMPRIMIDOS

Viatris Healthcare Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 9, 2025
Approval ID: fa321d0ee8aaf129
Company: Viatris Healthcare Limited
Type: Standard

Approval Details

Approval Id: fa321d0ee8aaf129
Drug Cima Aemps Name: LEPONEX 200 MG COMPRIMIDOS
Register Number: 90232
Holder Company Name: Viatris Healthcare Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.
Holder Company Detail Path: /organization/7c934f1e93c2ec28/viatris-healthcare
Authorization Date: 2025-04-09
Dosage Form: COMPRIMIDO
Dose: 200 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Viatris Healthcare Limited
Company Detail Path: /organization/7c934f1e93c2ec28/viatris-healthcare

Company Information

Pharmaceutical Company Name: VIATRIS HEALTHCARE
Country Name: France
City Name: lyon,auvergne rhone alpes,country_fr
Address: 1 RUE DE TURIN

Active Ingredients

CLOZAPINA

200 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

fa321d0ee8aaf129

Type

Standard

Back to CIMA-AEMPS Approvals